Cora Biosciences

We are a newly launched, venture-backed biotech spinout from a leading academic institution, dedicated to transforming the treatment of serious diseases using next-generation antisense oligonucleotide (ASO) therapeutics. With a strong scientific foundation and a leadership team of experienced drug developers, we are building a pipeline of RNA-targeted therapies that address high unmet medical need.